Julie N. Graff, MD

Articles

AR-targeted therapies for advanced prostate cancer

October 14, 2021

Julie N. Graff, MD, of OHSU Knight Cancer Institute, comments on the impact of the availability of newer-generation androgen receptor inhibitors on treatment outcomes for patients with advanced prostate cancer.